Skip to main content
. Author manuscript; available in PMC: 2020 Dec 9.
Published in final edited form as: Nat Rev Dis Primers. 2015 Jul 30;1:15018. doi: 10.1038/nrdp.2015.18

Figure 6. The incidence of ESRD in patients with type 2 diabetes from the ADVANCE-ON trial.

Figure 6.

Incidence of end-stage renal disease (ESRD) stratified according to intervention arm, where patients were subjected to either blood pressure (BP) lowering or glucose lowering treatments. Data is presented for sites (n=144) that were able to follow the majority (≥85%) of patients surviving to participate in post-trial follow-up outlining the number of patients who progressed to ESRD and, of these, the number who were receiving renal replacement therapy (RRT) and the number who had died as a result of kidney disease (renal death). Neither treatment significantly reduced the incidence of ESRD154..